NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000052910

Registered date:27/11/2023

Investigation of the Effect of Remimazolam on Circulatory Management in Transurethral Resection of Bladder Tumor with 5-Aminolevulinic Acid

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedMuscle layer non-invasive bladder cancer
Date of first enrollment2023/12/31
Target sample size200
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeIntraoperative minimum mean blood pressure value and duration
Secondary OutcomeCirculatory Agonist Usage

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) TUR-Bt patients who used anesthesia maintenance drugs other than sevoflurane and remimazolam 2) TUR-Bt patients who did not use PDD 3) Patients who expressed their refusal to participate in this study through the information disclosure document 4) Other cases deemed inappropriate by the investigator.

Related Information

Contact

public contact
Name Katsuhiko Ishibashi
Address 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba Japan 260-8677
Telephone 043-222-7171
E-mail katsu1484@chiba-u.jp
Affiliation Chiba University Hospital Anesthesiology
scientific contact
Name Katsuhiko Ishibashi
Address 1-8-1, Inohana, Chuo-ku, Chiba-shi, Chiba Japan
Telephone 043-222-7171
E-mail katsu1484@chiba-u.jp
Affiliation Chiba University Hospital Anesthesiology